Signal Peptide Peptidase (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human Signal Peptide Peptidase (HM13/SPP, UniProt Q8TCT9), expressed in HEK293 cells. Suited for intramembrane protease activity assays, inhibitor profiling, and antibody validation studies.
Expression system
HEK293
Cat. #
REC-SignalPeptidePeptidase

In stock

SKU
REC-SignalPeptidePeptidase
$498.00

Target Overview

Signal Peptide Peptidase (SPP; gene HM13, UniProt Q8TCT9) is a 377-amino-acid intramembrane aspartyl protease resident in the endoplasmic reticulum membrane. It belongs to the GxGD-type presenilin-fold family and carries the catalytic aspartate motifs characteristic of this clan. The recombinant protein is produced in HEK293 cells, which support the mammalian glycosylation and membrane-topology requirements that are critical for preserving the native fold and catalytic competence of multi-pass integral membrane proteases. SPP catalyzes the proteolytic cleavage of signal peptides within the plane of the ER membrane after they have been removed from secretory and membrane protein precursors. Substrates characterised in the literature include MHC class I signal peptides (generating HLA-E-presented epitopes), the hepatitis C virus core protein signal peptide, PSEN1, and XBP1 isoform 1 in a DERL1/RNF139-dependent context. Researchers use this recombinant in several experimental formats. In fluorogenic or FRET-based substrate cleavage assays it provides a quantifiable source of intramembrane proteolytic activity for kinetic measurements. In inhibitor profiling studies — particularly with (Z-LL)₂-ketone and other peptidomimetic compounds — it serves as the enzymatic target for IC₅₀ determination. For biophysical work including thermal shift and binding assays, the HEK293-expressed material offers a human-sequence-matched reference. Researchers validating antibodies against SPP/HM13 can use this recombinant as a defined positive-control antigen. It is designed to pair directly with the Triple Point Biologics anti-Signal Peptide Peptidase antibody (SKU: RP-Signal Peptide Peptidase), which has been validated for Western blot applications. The recombinant provides a sequence-matched loading control and band-identity confirmation in those workflows.

Background

Signal Peptide Peptidase (SPP, encoded by HM13) is one of a small family of human intramembrane aspartyl proteases structurally related to the presenilins but operating in the opposite membrane orientation. Its primary biochemical role is the post-translocational cleavage of signal peptides that are liberated from secretory protein precursors by signal peptidase, completing their clearance from the ER membrane. Beyond this housekeeping function, SPP generates immunologically active peptide fragments: proteolytic processing of MHC class I leader sequences by SPP produces nonamers loaded onto HLA-E, contributing to NK-cell recognition — a link that has made SPP a subject of immunology research. HM13/SPP has been studied as a research target across several disease-relevant contexts. In atherosclerosis research, Cao et al. (2025, Adv Sci) demonstrated that macrophage HM13/SPP promotes foamy macrophage formation and atherogenic lesion development in cell and animal models, placing SPP in lipid-metabolism and inflammation biology. In virology, Qiao et al. (2025, PNAS) used druggable genome screens to identify SPP as an antiviral host factor required by multiple flaviviruses — findings consistent with the earlier proposed role of SPP in processing flavivirus and hepatitis C virus polyprotein-derived signal peptides — and characterised SPP inhibition as a strategy investigated in antiviral model systems. In oncology, Jin et al. (2025, Tissue Cell) examined HM13 expression in colorectal cancer specimens and its relationship to PI3K/Akt and p53 pathway activity, while Zhang et al. (2026, Cell Death Dis) identified HM13 isoform switching events associated with esophageal adenocarcinoma patient survival in transcriptomic analyses. These studies collectively reflect how SPP is investigated across immunology, vascular biology, infectious disease, and cancer research. Because SPP is an integral membrane protease, producing enzymatically relevant recombinant material requires a eukaryotic expression system that supports correct membrane integration and folding. HEK293-expressed recombinant SPP retains the human sequence context needed to reproduce substrate recognition observed in published biochemical studies, making it the preferred form for inhibitor characterisation, substrate mapping, and antibody validation experiments in academic and pharmaceutical research settings.

Applications

  • Fluorogenic intramembrane substrate cleavage assay (e.g., signal-peptide-derived FRET peptide substrates)
  • Inhibitor IC50 determination using peptidomimetic compounds such as (Z-LL)₂-ketone
  • Antibody validation positive control — pairs with Triple Point Biologics anti-SPP antibody (SKU: RP-Signal Peptide Peptidase) for Western blot band-identity confirmation
  • Thermal shift / differential scanning fluorimetry assay for small-molecule binding characterisation
  • Pull-down or co-immunoprecipitation to map SPP protein–protein interactions (e.g., with DERL1 or RNF139)
  • Substrate identification by mass spectrometry using defined signal-peptide-derived peptide panels
  • Competition binding assay to rank inhibitor series by affinity against the human enzyme

References

  1. Cao Y et al. Macrophage HM13/SPP Enhances Foamy Macrophage Formation and Atherogenesis. Adv Sci (Weinh). 2025. doi:10.1002/advs.202412498. PMID: 40112173.
  2. Qiao W et al. Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses. Proc Natl Acad Sci U S A. 2025. doi:10.1073/pnas.2421573122. PMID: 39969998.
  3. Jin X et al. The role of HM13 expression and its relationship to PI3K/Akt and p53 signaling pathways in colorectal cancer. Tissue Cell. 2025. doi:10.1016/j.tice.2024.102702. PMID: 39755056.
  4. Zhang Y et al. Identification of isoform switching events linked with esophageal adenocarcinoma patient survival informs novel prognostic and therapeutic targets. Cell Death Dis. 2026. doi:10.1038/s41419-026-08542-2. PMID: 41807370.
  5. Inoue H et al. Rapid screening and identification of genes involved in bacterial extracellular membrane vesicle production using a curvature-sensing peptide. J Bacteriol. 2025. doi:10.1128/jb.00497-24. PMID: 40183544.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Subcellular localization not yet annotated

Frequently Asked Questions

What molecular weight does recombinant Signal Peptide Peptidase run at on SDS-PAGE?

The SPP polypeptide is 377 amino acids with a predicted unmodified MW of ~42 kDa. Because it is expressed in HEK293 cells, N-linked glycosylation and membrane-topology-driven anomalous SDS binding typically shift the apparent MW to ~45–50 kDa on reducing SDS-PAGE. If you are using this protein as a loading control or positive-control band, anticipate the smeared or diffuse migration pattern common to multi-pass integral membrane proteins solubilized in standard SDS-PAGE conditions. Running under non-reducing conditions may sharpen the band slightly.

Which isoform or processing form of SPP does this recombinant represent?

This recombinant corresponds to the full-length, catalytically active form of human SPP (HM13, UniProt Q8TCT9), encompassing all 377 amino acids including both catalytic aspartate-containing GxGD motifs. It is not a truncated or signal-peptide-cleaved fragment — the HEK293 expression system retains the native membrane topology during production. No propeptide processing event equivalent to classical aspartyl protease activation is documented for SPP; the full-length form is the active enzyme.

What substrates does Signal Peptide Peptidase cleave and how do I run an in vitro activity assay?

SPP cleaves signal peptides within the ER membrane after their Sec61 translocase-mediated removal. Well-characterized in vitro substrates include the MHC class I HLA-A2 signal peptide (used to generate the HLA-E nonapeptide epitope) and the hepatitis C virus core protein signal peptide. For fluorogenic activity assays, membrane-mimetic conditions are essential: reconstitute the reaction in detergent-containing buffer (0.1–0.5% CHAPSO or DDM work well in published SPP assays) supplemented with our standard buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl). FRET-based peptide substrates flanked with EDANS/DABCYL can be adapted from presenilin γ-secretase assay formats with SPP-specific cleavage site sequences.

What starting concentration of recombinant SPP should I use for an inhibitor IC50 assay?

A good starting point is 0.5–2 nM recombinant SPP per reaction well, titrating down if background hydrolysis of the fluorogenic substrate is too high. Because SPP is an intramembrane protease, detergent micelle composition substantially affects apparent Km and thus IC50 values — standardize your detergent lot and concentration before comparing inhibitor series. Known SPP inhibitors such as (Z-LL)2-ketone and helenalin serve as useful reference compounds to validate assay window (Z-score ≥ 0.5) before screening. Pre-incubate enzyme with inhibitor for 30 minutes at 37°C before substrate addition.

What buffer conditions are optimal for storing and diluting recombinant Signal Peptide Peptidase?

The protein is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, which stabilizes the detergent-solubilized membrane protein during storage. Store at -20°C in single-use aliquots; repeated freeze-thaw cycles cause aggregation and loss of activity. For working dilutions, use the same buffer supplemented with 0.05–0.1% DDM or CHAPSO to prevent hydrophobic aggregation at sub-micromolar concentrations. Avoid dilution into detergent-free aqueous buffers — SPP rapidly aggregates without a membrane-mimetic environment. Prepare dilutions fresh on the day of use and keep on ice.

Can I use this recombinant SPP as a positive control for Western blot with the matched anti-SPP antibody?

Yes — this recombinant is validated as a positive control for the matched rabbit polyclonal antibody (SKU: RP-Signal Peptide Peptidase; /anti-signal-peptide-peptidase-rabbit-polyclonal-antibody), which was raised and tested in the same laboratory. Both reagents were developed together specifically to guarantee this compatibility. Load 20–50 ng of recombinant SPP per lane on a standard 12% SDS-PAGE gel alongside your cell lysate samples. The antibody detects the ~45–50 kDa glycosylated band under reducing conditions, confirming antibody specificity before you commit to a full experimental blot.

How much recombinant Signal Peptide Peptidase should I load as a positive control for Western blot?

20–50 ng per lane is the recommended loading range when using the matched antibody (RP-Signal Peptide Peptidase). At 20 ng you should see a clean band without overwhelming adjacent lysate lanes; 50 ng is appropriate if you are running a sensitivity titration or validating a new secondary antibody. Dilute the stock in 1× Laemmli sample buffer containing 5% β-mercaptoethanol and heat at 70°C (not 95°C) for 5 minutes — harsh boiling of membrane proteins promotes aggregation and produces smeared or lost bands on transfer.

How does HEK293 expression preserve SPP activity compared to E. coli or baculovirus systems?

SPP is a 7-transmembrane aspartyl protease that absolutely requires correct membrane integration and mammalian-type glycosylation for catalytic competence. E. coli lacks the ER translocation machinery needed to insert multi-pass membrane proteins in the correct topology, typically yielding inclusion bodies. Baculovirus-insect cell systems can insert membrane proteins but provide partially truncated N-glycan structures that affect protein stability and folding. HEK293 expression replicates the mammalian ER environment, supporting native GxGD active-site geometry and full glycosylation, which is why this recombinant retains measurable intramembrane protease activity in detergent-reconstituted assays.

Validation imagery coming soon

Western blot validation figures for REC-SignalPeptidePeptidase will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →